Columbia researchers have found that giving a small dose of ketamine one week before a psychologically traumatic event may help prevent post-traumatic stress disorder.
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
Researchers from Columbia and the National Institute on Alcohol Abuse and Alcoholism have found that the number of Americans with marijuana use disorder has nearly doubled, but few get treatment.
Researchers have found that treatment with very low doses of a dopamine-1 receptor (D1R) agonist was not effective in reducing the cognitive and negative symptoms of schizophrenia.